USciences Bulletin - University of the Sciences in Philadelphia

THE BULLETIN: SCHOLARLY ACTIVITY PAGE 29
PHILADELPHIA COLLEGE
OF PHARMACY
Grant
CLYDE OFNER✦ received a oneyear
extension on his National
Institutes of Health, National
Cancer Institute, grant entitled
“A Biodegradable Doxorubicin
Conjugate for Enhanced Tumor
Uptake and Efficacy.”
Poster Presentations
J. Pearson+, B. Dubois+, ANIL
D’MELLO✦, G. Cherala+, “Effect
of Maternal Low Protein Diet
During Pregnancy and Lactation
in Rats on the Expression of Renal
OAT1” at the American Association
of Pharmaceutical Scientists
Annual Meeting, Washington, DC,
October 23–27, 2011.
GRACE EARL✦, ANNETTE
LISTA✭, SUSAN YOUSSEF✭,
LAURA PONTIGGIA✦, ANDREW
PETERSON✦, “Effectiveness
of Dietary Sodium Intervention
Provided by a Clinical Pharmacist
to Ambulatory Patients with Heart
Failure” at the American College of
Clinical Pharmacy Annual Meeting,
Pittsburgh, October 17, 2011.
SADAFF EJAZ✭, ASHLEY
AZAR✭, THOMAS H.
RUSHMORE✦, PETER J.
HARVISON✦, “Metabolism
of 3-(3,5-Dichlorophenyl)-
2,4-Thiazolidinedione (DCPT)
in Rat Liver Microsomes” at
the Society of Toxicology
Annual Meeting, San Francisco,
March 11–15, 2012.
THAO HUYNH✭, GRACE
JIANG✭, GRACE EARL✦,
“Promoting Critical Thinking
Through Discussion Forums
in Pre-Professional Doctor of
Pharmacy Students” at the 46th
American Society of Health-
System Pharmacists Mid-Year
Clinical Meeting, New Orleans,
December 6, 2011.
LEENA KANSAGRA✦,
QUINN A. CZOSNOWSKI✦,
CRAIG B. WHITMAN✦,
J. Sutton+, C. Schorr+,
B. Milcarek+, D. R. Gerber+,
“The Impact of Dexmedetomidine
Use on Duration of Mechanical
Ventilation in Critically Ill Medical
Patients” at the Society of Critical
Care Medicine Annual Congress,
Houston, February 7, 2012.
RANI J. QASEM✭, JING LI✭,
ELIZABETH YABLONSKI✭,
HEE MAN TANG✭, LAURA
PONTIGGIA✦, ANIL D’MELLO✦,
“Early Life Growth Restriction
Programs Chronic Hyperphagia
Mediated Through Central Leptin
Resistance in the Male Offspring”
at the Annual Scientific Meeting
of the Obesity Society, Orlando,
October 2, 2011.
Presentations
ADEBOYE ADEJARE✦, “Process
of Drug Discovery/Development
and Society” and “Graduate
Studies in U.S. Universities”
to faculty, staff, and students
at Makerere, Kampala, and
Stawa universities, Uganda,
January 23–27, 2012.
MICHAEL J. CAWLEY✦]
• “Hyponatremia in Hospitalized
Patients: A Guide for Improving
Patient Outcomes and Reducing
Health-System Costs” at the
Pharmacy Learning Network
Philadelphia Conference
Regional Meeting, Philadelphia,
March 30–31, 2012.
• “Ask the Experts: Issues Related
to Managing Hyponatremia in
Hospitalized Patients” as part
of a Continuing Education
Webinar for ASHP Advantage,
February 15, 2012.
• “Management of Hyponatremia
in Hospitalized Patients: Role
of Pharmacists in Improving
Patient Care” at the 46th
American Society of Health-
Unlocking the Mystery
of a Liver Disease
By Brian Kirschner
JOHN PORTER, PhD, professor and biology
graduate programs director at USciences, is hoping
that unlocking the structure of compounds in red
pigweed will lead to a mechanism and cure for
biliary atresia, a bile duct disease that affects about
1 in every 10,000 infants and, in most cases,
eventually requires a liver transplant.
“Understanding the
cause of the disease
in humans is an
ultimate goal.”
- JOHN PORTER, PhD
Working in conjunction with a team from the
University of Pennsylvania, Dr. Porter received a
four-year grant from the National Institutes of
Health (NIH) on October 1, 2011, for the isolation,
identification, and characterization of a toxin that
can cause a syndrome similar to biliary atresia.
The project started in 2007 when gastroenterologist
Rebecca G. Wells, MD, of the Perelman School of
Medicine at the University of Pennsylvania, wanted
to read more about the 1964 and 1989 epidemics of
biliary atresia in Australian lambs, which were
attributed to consumption of unusual plants by
pregnant ewes during severe droughts. Dr. Wells
Continued on page 31